New Drug Review System to be revamped.

The KFDA plans to revamp the new drug review system by intensifying the pre-review controls and the obligation compliances through the working guideline revision. The KFDA has admitted the review system unnecessary and the number of supervisory activities appeared negligible mainly due to the lack of its understanding by the industry.

Besides, the KFDA found a lot of problems and mistakes, w...